Abbott’s prostate cancer drug Xinlay unapprovable: US FDA 15 Sep, 2005
US FDA rejects Pfizer's new osteoporosis drug 15 Sep, 2005
Epilepsy drug rufinamide: Eisai seeks US FDA nod 15 Sep, 2005
US FDA approves Takeda’s drug combo for type 2 diabetes
US FDA stalls Roche’ Accutane use in pregnancy
Novo Nordisk’s 24-hour acting insulin Levemir gets US FDA okay
US FDA approves Teva's generic for osteoporosis
Barr, Teva get fexofenadine approvals from US FDA
Barr gets US FDA okay for clonazepam tabs
FDA tightens restrictions on acne drug
FDA okays acrylic lens for cataract patients
USFDA’s recall overdrive creates panic among drug users
Roche gets USFDA approval for oral Xeloda
Glaxo applies for FDA approval for Flaurix
US FDA to decide on Plan B morning-after pill by Sept 1
Painkiller patch Duragesic under US FDA probe over patients deaths
Teva gets US FDA nod for mirtazapine anti-depressant
FDA directs Palladone withdrawal
Zidovudine by Ranbaxy gets US FDA tentative nod
Guidant defibrillator recall: US FDA makes three classifications
AIDS drug stavudine by Aurobindo Pharma gets tentative US FDA
US FDA to source anti-HIV drugs from Indian firms
FDA warning on abortion drug Mifeprex (Mifepristone)
US FDA recalls Baxter’s intravenous pumps
US FDA grants tentative nod to Ranbaxy’s glimepiride
Insomnia treatment: ROZEREM approved by FDA
US FDA grants fast track status for GSK’s HIV drug
Halozyme gets FDA nod for bladder cancer therapy
Ranbaxy gets US FDA nod for sumatriptan tabs
US FDA approval for Orchid's ceftriaxone vials
IVAX gets FDA okay for hydrochlorothiazide caps
Ranbaxy gets USFDA nod for glimepiride tabs
US FDA blocks sale of Pharmakon's illegal drugs
Latest updates Contact Us - Feedback About Us
US
FDA News